Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hew

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Directed evolution of hyperactive integrases for site specific insertion of transgenesBrian E Hew, Sabranth Gupta, Ryuei Sato, et al.
Nucleic Acids Research|July 2, 2024
Directed evolution of hyperactive integrases for site specific insertion of transgenesBrian E Hew, Sabranth Gupta, Ryuei Sato, et al.
Cancer Medicine|January 24, 2013
Significance of lymphovascular space invasion in epithelial ovarian cancerKoji Matsuo, Todd B Sheridan, Kiyoshi Yoshino, et al.
Advances in Experimental Medicine and Biology|November 26, 2008
Derivatives of human complement component C3 for therapeutic complement depletion: a novel class of therapeutic agentsDavid C Fritzinger, Brian E Hew, June Q Lee, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Gene-sized DNA insertion at genomic safe harbors in human cells using a site-directed transposaseJames E Short, Lisa Sharek, Joshua F Meckler, et al.
Nucleic Acids Research|December 8, 2025
Gene-sized DNA insertion at genomic safe harbors in human cells using a site-directed transposaseJames E Short, Lisa Sharek, Joshua F Meckler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2018
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like CellsFiona Simpkins, Kibeom Jang, Hyunho Yoon, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
The exocyst is an insulin-sensitive regulator of amyloid precursor protein trafficking and amyloid-beta generation in neuronsChantell Balaan, Geetika Y Patwardhan, Rachel K Sachs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian CancerKarina E Hew, Philip C Miller, Dorraya El-Ashry, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Directed evolution of hyperactive integrases for site specific insertion of transgenesBrian E Hew, Sabranth Gupta, Ryuei Sato, et al.
Nucleic Acids Research|July 2, 2024
Directed evolution of hyperactive integrases for site specific insertion of transgenesBrian E Hew, Sabranth Gupta, Ryuei Sato, et al.
Cancer Medicine|January 24, 2013
Significance of lymphovascular space invasion in epithelial ovarian cancerKoji Matsuo, Todd B Sheridan, Kiyoshi Yoshino, et al.
Advances in Experimental Medicine and Biology|November 26, 2008
Derivatives of human complement component C3 for therapeutic complement depletion: a novel class of therapeutic agentsDavid C Fritzinger, Brian E Hew, June Q Lee, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Gene-sized DNA insertion at genomic safe harbors in human cells using a site-directed transposaseJames E Short, Lisa Sharek, Joshua F Meckler, et al.
Nucleic Acids Research|December 8, 2025
Gene-sized DNA insertion at genomic safe harbors in human cells using a site-directed transposaseJames E Short, Lisa Sharek, Joshua F Meckler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2018
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like CellsFiona Simpkins, Kibeom Jang, Hyunho Yoon, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
The exocyst is an insulin-sensitive regulator of amyloid precursor protein trafficking and amyloid-beta generation in neuronsChantell Balaan, Geetika Y Patwardhan, Rachel K Sachs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian CancerKarina E Hew, Philip C Miller, Dorraya El-Ashry, et al.
Pageof 4